Mechanistically, insulin resistance and the resultant hyperinsulinemia promotes endometrial carcinogenesis and progression by the direct pro-proliferative and anti-apoptotic effect of insulin and insulin growth factor (IGF-1) on endometrial cells (14, 15). This evidence concerns the gene INS and Insulin resistance.